Squamous non small cell lung cancer (NSCLC-SCC)

Clinical trials for Squamous non small cell lung cancer (NSCLC-SCC) explained in plain language.

Never miss a new study

Get alerted when new Squamous non small cell lung cancer (NSCLC-SCC) trials appear

Sign up with your email to follow new studies for Squamous non small cell lung cancer (NSCLC-SCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental cancer drug GEN1047 tested in humans – study halted early

Disease control Stopped early

This study tested a new drug called GEN1047 in people with advanced solid tumors (breast, endometrial, ovarian, or lung cancer) who had no other treatment options. The goal was to check safety, side effects, and how the body processes the drug. The study was terminated early, but…

Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC-SCC)

Phase 1/2 • Sponsor: Genmab • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC

Squamous non small cell lung cancer (NSCLC-SCC)

Get alerted when new Squamous non small cell lung cancer (NSCLC-SCC) trials appear

Experimental cancer drug GEN1047 tested in humans – study halted early